Antimicrobial Envelopes for Cardiac Device Infection Prevention: A Meta-Analysis of Randomized and Matched Studies

Area of Science:

• Cardiology
• Infectious Diseases
• Medical Devices

Background:

• Cardiac implantable electronic device (CIED)-associated infections are a significant complication.
• Antimicrobial envelopes are a potential strategy to reduce CIED infection risk.
• Existing evidence on their prognostic benefit is inconclusive.

Purpose of the Study:

• To evaluate the efficacy of antimicrobial envelopes in preventing CIED-related infections.
• To compare antimicrobial envelopes with standard prophylactic measures.
• To analyze data from randomized controlled trials and propensity score-matched cohorts.

Main Methods:

• Meta-analysis of one RCT and eight observational studies.
• Inclusion of 78,587 patients, with 15.6% receiving antimicrobial envelopes.
• Primary outcomes: any CIED infection and major CIED infection; sensitivity analysis in high-risk patients.

Main Results:

• Overall analysis showed no significant difference in infection rates (RR 0.55; 95% CI 0.30-1.01).
• Time-to-event analysis indicated a significantly lower risk of any CIED infection (HR 0.38; 95% CI 0.17-0.87) and major CIED infection (HR 0.54; 95% CI 0.39-0.76).
• Antimicrobial envelopes significantly reduced infection risk in high-risk patients (RR 0.64; 95% CI 0.47-0.88).

Conclusions:

• Antibacterial envelopes significantly reduce CIED-related infection risk, particularly in high-risk individuals.
• Time-to-event findings support their use in appropriately stratified patients.
• Cost-effectiveness requires consideration alongside observed benefits.